دورية أكاديمية

Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry.

التفاصيل البيبلوغرافية
العنوان: Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry.
المؤلفون: Chetboun, Mikael, Drumez, Elodie, Ballou, Cassandra, Maanaoui, Mehdi, Payne, Elizabeth, Barton, Franca, Pattou Kerr-Conte, Julie, Vantyghem, Marie-Christine, Piemonti, Lorenzo, Rickels, Michael R., Labreuche, Julien, Pattou, Francois
المساهمون: Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Recherche translationnelle sur le diabète - U 1190 (RTD), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS), Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), IRCCS Ospedale San Raffaele Milan, Italy, University of Pennsylvania, Perelman School of Medicine
المصدر: ISSN: 2213-8587.
بيانات النشر: HAL CCSD
Elsevier
سنة النشر: 2023
المجموعة: LillOA (HAL Lille Open Archive, Université de Lille)
مصطلحات موضوعية: [SDV]Life Sciences [q-bio]
الوصف: International audience ; BackgroundAllogeneic islet transplantation is a validated therapy in type 1 diabetes; however, there is decline of transplanted islet graft function over time and the mechanisms underlying this decline are unclear. We evaluated the distinct association between primary graft function (PGF) and 5-year islet transplantation outcomes.MethodsIn this retrospective, multicentre, observational cohort study, we enrolled all patients from the Collaborative Islet Transplant Registry who received islet transplantation alone (ITA recipients) or islet-after-kidney transplantation (IAK recipients) between Jan 19, 1999, and July 17, 2020, with a calculable PGF (exposure of interest), measured 28 days after last islet infusion with a validated composite index of islet graft function (BETA-2 score). The primary outcome was cumulative incidence of unsuccessful islet transplantation, defined as an HbA1c of 7·0% (53 mmol/mol) or higher, or severe hypoglycaemia (ie, requiring third-party intervention to correct), or a fasting C-peptide concentration of less than 0·2 ng/mL. Secondary outcomes were graft exhaustion (fasting C-peptide <0·3 ng/mL); inadequate glucose control (HbA1c ≥7·0% [53 mmol/mol] or severe hypoglycaemia); and requirement for exogenous insulin therapy (≥14 consecutive days). Associations between PGF and islet transplantation outcomes were explored with a competing risk analysis adjusted for all covariates suspected or known to affect outcomes. A predictive model based on PGF was built and internally validated by using bootstraps resampling method.FindingsIn 39 centres worldwide, we enrolled 1210 patients with a calculable PGF (of those without missing data, mean age 47 years [SD 10], 712 [59·5%] were female, and 865 (97·9%) were White), who received a median of 10·8 thousand islet-equivalents per kg of bodyweight (IQR 7·4–13·5). 986 (82·4%) were ITA recipients and 211 (17·6%) were IAK recipients. Of 1210 patients, 452 (37·4%) received a single islet infusion and 758 (62·6%) received ...
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37105208; hal-04546266; https://hal.univ-lille.fr/hal-04546266Test; PUBMED: 37105208
DOI: 10.1016/S2213-8587(23)00082-7
الإتاحة: https://doi.org/10.1016/S2213-8587Test(23)00082-7
https://hal.univ-lille.fr/hal-04546266Test
رقم الانضمام: edsbas.13020BD0
قاعدة البيانات: BASE